Trademark Overview
On Monday, July 8, 2024, a trademark application was filed for BRYSURQ with the United States Patent and Trademark Office. The USPTO has given the BRYSURQ trademark a serial number of 79402375. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, February 3, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The BRYSURQ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention ...
![brysurq](https://cdn.furm.com/trademarks/79402375/14a0faaebde7708747be635104b04c96.jpg)